Mesa científica |
Título |
Ponente |
How safe is cardiac imaging? |
Radiation dose from cardiac computed tomography and nuclear cardiology |
Einstein A J (New York, US) |
How safe is cardiac imaging? |
Gadolinium risks |
Erbel R (Essen, DE) |
How safe is cardiac imaging? |
Ultrasound contrast agents - are they safe? |
DeMaria A (San Diego, US) |
How safe is cardiac imaging? |
Implications of risk-benefit analyses in clinical practice |
Picano E (Pisa, IT) |
The strengths of the imaging modalities in coronary artery disease - changing roles |
The value of echocardiography. The viewpoint of a nuclear imaging expert |
Knuuti J M (Turku, FI) |
The strengths of the imaging modalities in coronary artery disease - changing roles |
The value of cardiovascular magnetic resonance. The viewpoint of an echocardiographer |
Nihoyannopoulos P (London, GB) |
Cardiovascular imaging in multimodality environment |
When cardiovascular imaging is appropriate |
Gibbons R (Rochester, US) |
Cardiovascular imaging in multimodality environment |
Detection of early disease |
Achenbach S (Erlangen, DE) |
Cardiovascular imaging in multimodality environment |
Multimodality imaging in coronary heart disease |
Bonow R (Chicago, US) |
Cardiac imaging in 2020 |
Combination of anatomic and perfusion assessment is the future |
Gibbons R (Rochester, US) |
Cardiac imaging in 2020 |
Cardiac ultrasound will do it all |
Marwick T H (Brisbane, AU) |
Cardiac imaging in 2020 |
Combined imaging techniques will be the standard |
Rademakers F E (Leuven, BE) |
Cardiac computed tomography in coronary artery disease: when to use and when not to use |
Cardiac computed tomography for risk stratification |
Weigold W G (Washington, US) |
Cardiac computed tomography in coronary artery disease: when to use and when not to use |
Suspected coronary artery disease |
Achenbach S (Erlangen, DE) |
Imaging valve disease in 2008 |
Resting echocardiography is all you need |
Thomas J D (Cleveland, US) |
Imaging valve disease in 2008 |
Functional assessment is mandatory |
Pierard L A (Liege, BE) |
The year in clinical imaging |
Echocardiography |
DeMaria A (San Diego, US) |
The year in clinical imaging |
Image fusion |
Reiber J H C (Leiden, NL) |
Highlight Session |
Imaging |
Pierard L A (Liege, BE) |
The year in clinical imaging |
Cardiovascular magnetic resonance |
F E Rademakers (Leuven, BE) |
The strengths of the imaging modalities in coronary artery disease - changing roles |
The value of computed tomography angiography. The viewpoint of an interventionalist |
P J De Feyter (Rotterdam, NL) |
Cardiac computed tomography in coronary artery disease: when to use and when not to use |
Bypass grafts and stents |
S Schroeder (Goeppingen, DE) |
Imaging valve disease in 2008 |
What is the value of magnetic resonance imaging and computed tomography? |
J-L Vanoverschelde (Brussels, BE) |
The strengths of the imaging modalities in coronary artery disease - changing roles |
The value of nuclear imaging. The viewpoint of a cardiovascular magnetic resonance expert |
J Schwitter (Zurich, CH) |